Medicinal composition for treating neurasthenia

Abstract

The invention relates to medicinal composition for treating neurasthenia. The medicinal composition is characterized by comprising the following raw materials in parts by weight: 45-55 parts of dogwood fruit pulp, 12-18 parts of glossy privet fruit, 20-30 parts of Chinese yam, 12-18 parts of schisandra chinensis, 10-15 parts of fructus rosae laevigatae, 15-20 parts of dodder, 15-25 parts of crude dragon bone, 15-25 parts of polygonum multiflorum, 15-25 parts of wild jujube seed, 18-28 parts of arisacma consanguineum, 20-25 parts of amber, 15-25 parts of raw oyster, 15-25 parts of angelica and 12-18 parts of peony root bark. Several times of clinical formulation and compatibility of the Chinese herbs prove that after the medicinal composition is drunk, the medicinal composition treats both symptoms and root causes by starting from the overall condition of a human body, and has the effects of nourishing the heart and the kidney, tonifying the heart and the spleen and the like; hundreds of clinical trials prove that the medicinal composition has a significant therapeutic effect on the neurasthenia, with the effective rate of 98.56% and high curative rate.

Description

technical field [0001] The invention relates to a traditional Chinese medicine for treating diseases, in particular to a pharmaceutical composition for treating neurasthenia. Background technique [0002] Neurasthenia is the most common neurosis in clinical practice. Its onset is often caused by excessive tension of higher nervous activity, or temporary dysfunction of the liver and fu organs after a serious illness and prolonged illness. The symptoms of this disease are various. The main symptoms are dizziness, headache, tinnitus, memory loss, physical fatigue, inattention, upset, easy temper tantrum, insomnia at night, lack of energy during daytime work, back pain, heartbeat and shortness of breath. , shortness of breath, chest pain, sweating, poor appetite, full stomach, belching, vomiting, diarrhea or constipation, or impotence, premature ejaculation, nocturnal emission and other symptoms, including dizziness, headache, tinnitus, memory loss, physical fatigue, inability t...

AI Technical Summary

Problems solved by technology

[0003] The technical problem to be solved by the present invention is to provide a pharmaceutical composition for treating neurasthenia, so as to solve the problems that the medicine group for treating neurasthenia cannot be comprehensively administered, the treatment effect is not good, and the symptoms are not cured.